The global CAR T-cell therapy market is experiencing significant growth, fueled by increasing acceptance of this innovative treatment for a range of malignancies. Key drivers shaping the market include growing prevalence of cancer, advancements in technology, and supportive policies. The market is characterized by a competitive landscape with nume